|
|
Volumn 94, Issue 20, 2002, Pages 1520-1521
|
|
First clinical trials of endostatin yield lukewarm results
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ENDOSTATIN;
ANTINEOPLASTIC ACTIVITY;
CANCER PATIENT;
CLINICAL TRIAL;
DRUG RESEARCH;
DRUG SAFETY;
HUMAN;
MELANOMA;
NEUROENDOCRINE TUMOR;
NOTE;
PRIORITY JOURNAL;
SARCOMA;
TUMOR BIOPSY;
|
|
EID: 0037120985
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/94.20.1520 Document Type: Note |
|
Times cited : (29)
|
|
References (0)
|